Valuation: Old API Wind-down Ltd.

Market Cap 87.35T 77.61T 72.44T 66.03T 1L 83.97L 1L 9L 3L 42.93L 3L 3L 1.38Cr P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 25Cr 22Cr 20Cr 19Cr 35Cr 2.36TCr 35Cr 246.62Cr 96Cr 1.21TCr 92Cr 90Cr 3.88TCr EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.61%-3.43%+36.07%+117.61% 1,01900Cr
-1.02%-5.60%+35.72%+64.82% 62TCr
+1.11%-0.58%+12.36%+78.27% 46TCr
+0.34%-3.01%+61.79%+41.79% 36TCr
-0.95%-4.05%+20.54%+40.33% 33TCr
-1.46%-2.89%+10.57%+26.54% 27TCr
-1.35%-5.43%-6.17%+8.82% 24TCr
-1.04%-2.79%+35.30%+54.42% 22TCr
-1.87%-4.10%+28.44%+97.54% 18TCr
Average -0.68%-3.05%+26.07%+58.90% 36.97TCr
Weighted average by Cap. -0.60%-3.33%+29.07%+71.15%

Financials

2016 2017
Net sales 5.43Cr 4.82Cr 4.5Cr 4.1Cr 7.74Cr 521.71Cr 7.81Cr 54Cr 21Cr 266.71Cr 20Cr 20Cr 855.96Cr 11Cr 9.41Cr 8.79Cr 8.01Cr 15Cr 1.02TCr 15Cr 106.32Cr 41Cr 520.67Cr 40Cr 39Cr 1.67TCr
Net income -10Cr -9.15Cr -8.54Cr -7.78Cr -15Cr -989.96Cr -15Cr -103.34Cr -40Cr -506.08Cr -39Cr -38Cr -1.62TCr -13Cr -11Cr -10Cr -9.46Cr -18Cr -1.2TCr -18Cr -125.65Cr -49Cr -615.31Cr -47Cr -46Cr -1.97TCr
Net Debt 21Cr 19Cr 17Cr 16Cr 30Cr 2.01TCr 30Cr 210.24Cr 81Cr 1.03TCr 79Cr 77Cr 3.3TCr 25Cr 22Cr 20Cr 19Cr 35Cr 2.36TCr 35Cr 246.53Cr 96Cr 1.21TCr 92Cr 90Cr 3.87TCr
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock